Literature DB >> 13852570

Investigation of hyperparathyroidism in the absence of bone disease.

R D HYDE, R V JONES, R R McSWINEY, F T PRUNTY.   

Abstract

Entities:  

Keywords:  PARATHYROID GLANDS/diseases

Mesh:

Year:  1960        PMID: 13852570     DOI: 10.1016/s0140-6736(60)90171-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  MAXIMAL TUBULAR RESORPTIVE RATE FOR INORGANIC PHOSPHATE IN HYPERPARATHYROIDISM.

Authors:  J ANDERSON; V PARSONS
Journal:  Br Med J       Date:  1964-05-02

2.  [RESEARCH ON RENAL PHOSPHATE EXCRETION IN PATIENTS WITH VARIOUS NEPHROPATHIES WITH PARTICULAR CONSIDERATION OF PATIENTS WITH PRIMARY HYPERPARATHYROIDISM].

Authors:  H D HORN; H NIETH; G GROTE
Journal:  Klin Wochenschr       Date:  1964-10-15

3.  The separate effects of hyperparathyroidism, hypercalcemia of malignancy, renal failure, and acidosis on the state of calcium, phosphate, and other ions in plasma.

Authors:  M WALSER
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

4.  Diagnosis of hyperparathyroidism in patients presenting with urinary calculi.

Authors:  D J OAKLAND
Journal:  Br Med J       Date:  1963-07-27

5.  Diagnosis of primary hyperparathyroidism.

Authors:  B E NORDIN
Journal:  Proc R Soc Med       Date:  1961-08

6.  Hyperparathyroidism.

Authors: 
Journal:  Br Med J       Date:  1962-12-08

7.  [Calcium and phosphate loading test for the diagnosis of primary hyperparathyroidism].

Authors:  O Meffert
Journal:  Klin Wochenschr       Date:  1973-06-01

8.  [Clinical and biochemical studies of glucosephosphate isomerase of normal human erythrocytes and in glucosephosphate isomerase deficiency].

Authors:  H Arnold; K G Blume; D Busch; U Lenkeit; G W Löhr; E Lübs
Journal:  Klin Wochenschr       Date:  1970-11-01

9.  Assessment of urinary phosphate excretion in normal and abnormal children.

Authors:  H Janse; H H van Gelderen; J H Ruys
Journal:  Arch Dis Child       Date:  1966-10       Impact factor: 3.791

10.  Osteomalacia after prolonged glutethimide administration.

Authors:  R H Greenwood; F T Prunty; J Silver
Journal:  Br Med J       Date:  1973-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.